This Week's Exclusive

The introduction of effective antiemetic regimens in recent years has led many clinicians to assume that CINV is no longer a major problem. However, nausea and vomiting are frequent complications of cancer treatment, occurring in up to 80% of patients receiving chemotherapy. Although CINV can be prevented in most patients with the use of guideline-recommended antiemetic regimens, Rebecca Clark-Snow, RN, BSN, OCN and colleagues (2018) recently revealed low adher...

Top Oncology Stories

Tuesday, December 18, 2018
Cancer diagnoses do not always come with a predictable future; sometimes, the impending course of the disease is uncertain. However, this terrifying unknown may soon be a th...
Friday, December 14, 2018
A cellular abnormality called cervical intraepithelial neoplasia (CIN) is a precursor for cervical cancer. However, scientists have now found that women who are positive for...
Thursday, December 13, 2018
After granting Priority Review, the FDA has approved atezolizumab (Tecentriq®, Genentech, Inc.), a monoclonal antibody, to be used in combination with carboplatin/paclitaxel/bevaci...
Thursday, December 13, 2018
In a new study, investigators discovered that younger women diagnosed with breast cancer have poorer prognoses compared with their older counterparts. This link is specific ...
Wednesday, December 12, 2018
Chemotherapy is a life-saving treatment for many patients with cancer. However, it can also leave patients with lasting neurological deficits through a condition commonly known as ...

Expert Perspectives

​Brain and spinal cord tumors are the second most common cancers in children, accounting for 1 out of 4 childhood cancers. Despite intensive treatment, children with histologically diagnosed high-risk medulloblastoma, supraten...
Immunotherapies such as PD-1 inhibitors have improved survival for many patients with cancer. However, these therapies are associated with adverse events that, if not properly managed, impair quality of life and may lead to treatm...
For oncology nurses, certification has a significant impact on career advancement and quality care. Since oncology is a rapidly changing field, up-to-date study materials are therefore crucial. To this end, Oncology Nursing Review...
Metastatic breast cancer (MBC) is associated with a poor prognosis, and patients often develop refractory or resistant disease, adverse events, depression, and financial hardship. Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN®, office practice nurse in ...
Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease...

Original Research

In order to identify the continuing medical education needs and preferences of hematology/oncology fellows, i3 Health administered a survey to participants at several live CME-certified visiting faculty meetings. i3 Health inte...
Chronic myeloid leukemia (CML) accounts for 15% of all adult leukemias and is characterized by heterogenous clinical manifestations. In recent years outcomes for patients with CML have greatly improved, in part due to the a...
Many patients with cancer who receive systemic therapy experience cancer treatment-related cognitive impairment, commonly referred to as "chemo brain." Chemo brain is characterized by the inability to remember certain thing...
The incidence of suicide among patients with cancer in the United States is twice that of the general population. Studies demonstrate that demoralization, defined as lowered morale and perceived incapacity to cope, is stron...
Chronic lymphocytic leukemia (CLL) has a heterogenous disease course, and questions remain regarding when to initiate therapy, the application of prognostic markers, and the optimal regimens and sequences of agents for individual patients. At the Onc...
© Copyright 2018 i3 Health. All rights reserved.